e-learning
resources
Madrid 2019
Monday, 30.09.2019
Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metformin meliorated glucocorticoid resistance through activating AMPK in septic rat
H. Liang (Zhengzhou, China), X. Ding (Zhengzhou, China), T. Sun (Zhengzhou, China), J. Sun (Zhengzhou, China)
Source:
International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Session:
Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Session type:
Thematic Poster
Number:
2269
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Liang (Zhengzhou, China), X. Ding (Zhengzhou, China), T. Sun (Zhengzhou, China), J. Sun (Zhengzhou, China). Metformin meliorated glucocorticoid resistance through activating AMPK in septic rat. 2269
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
Insulin resistance exacerbates lung inflammation in obese patients via PI3K/Akt signaling pathway
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
Formoterol restores oxidative stress-induced corticosteroid insensitivity via activation of protein phosphatase PP2A
Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways
Year: 2012
Corticosteroid effects on cell signalling
Source: Eur Respir J 2006; 27: 413-426
Year: 2006
Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
Involvement of C/EBPbeta and delta in lung glucocorticoid signaling
Source: Eur Respir J 2002; 20: Suppl. 38, 372s
Year: 2002
6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
The GLP-1 receptor agonist Liraglutide attenuates intermittent hypoxia-induced pro-inflammatory macrophage polarization in primary macrophages
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021
AICAR decreases acute lung injury by phosphorylating AMPK and upregulating heme oxygenase-1
Source: Eur Respir J, 58 (6) 2003694; 10.1183/13993003.03694-2020
Year: 2021
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
Source: Eur Respir J 2010; 35: 750-756
Year: 2010
TNFα-induced glucocorticoid resistance: Effect of steroidal and non-steroidal GR agonists, formoterol and inhibition of inflammatory signalling
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta - glucocorticoid receptor signaling axis
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015
Activated protein phosphatase PP2A by formoterol enhances nuclear translocation of glucocorticoid receptor induced by budesonide
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Dual endothelin-1 receptor antagonism prevents chronic intermittent hypoxia-induced cardiovascular alterations in rats
Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing
Year: 2008
FoxO1 activation protects against IL-6-mediated perinatal metabolic programming of lung micro-vessels
Source: International Congress 2019 – Molecular and experimental paediatric lung disease
Year: 2019
The serum and glucocorticoid inducible kinase in alveolar transport regulation
Source: Annual Congress 2009 - Novel regulators of alveolar liquid clearance
Year: 2009
Effects of combination treatments with the PPAR β/δ agonist GW0742 and the phosphodiesterase type V inhibitor, sildenafil on markers of pulmonary hypertension in hypoxic rats
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Corticosteroids reduce pro-inflammatory cytokine expression in airway smooth muscle cells via upregulation of MAPK phosphatase-1 and inhibition of p38 MAPK signalling
Source: Eur Respir J 2005; 26: Suppl. 49, 713s
Year: 2005
Pharmacological activation of Nur77 enhances BMP signalling and inhibits vascular remodelling in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept